Calroy’s mission is to combat the world’s most challenging health issues with pioneering scientific research and the development of new botanical formulas.
Our innovations are already enabling thousands of people to live healthier and more fulfilling lives.
In partnership with its academic collaborators, Calroy has developed a completely new approach to cardiovascular support.
The focus of the company’s research effort is the protection of the endothelium.
Understanding that almost all cardiovascular challenges begins with injury to the endothelium, Calroy is focused on the health of the endothelial glycocalyx, a microscopic gel-like lining that naturally protects the endothelium. When the glycocalyx is breached, cholesterol can lodge under endothelial cells, initiating the inflammatory response that leads to plaque formation and thrombotic events. It transpires that the endothelial glycocalyx is exceptionally vulnerable to collapse through poor diet, disease, stress and aging.
Arterosil® is a non-prescription nutraceutical proven to rebuild the endothelial glycocalyx.
The endothelial glycocalyx is a thin gel-like layer that coats the entire luminal side of the vascular endothelium. It is the gatekeeper to the endothelium and therefore plays a critical role in cardiovascular health.
Arterosil® is available through licensed healthcare practitioners only.
US and International Patents Pending